Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

314.39 +9.64 (+3.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... 
Via Benzinga
Exposures Product Safety
3 Things About CRISPR Therapeutics That Smart Investors Know
The company is on track to be the first to market with a gene-editing therapy for blood disorders. 
Via The Motley Fool
Where Vertex Pharmaceuticals Stands With Analysts
Within the last quarter, Vertex Pharmaceuticals (NASDAQ:VRTX 
Via Benzinga
Expert Ratings For Vertex Pharmaceuticals
Within the last quarter, Vertex Pharmaceuticals (NASDAQ:VRTX 
Via Benzinga
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Can one multibillion-dollar blockbuster breakthrough lead to another? 
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
2 Top Biotech Stocks to Buy Right Now
Both of these companies have successfully developed breakthrough medicines. 
Via The Motley Fool
Carnival And American Airlines Lead The SPY Higher Tuesday
U.S. indices were trading higher Tuesday amid a rebound in reopening stocks, which dipped Monday amid Delta variant concerns. The... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ: 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Citigroup boosted International Business Machines Corporation (NYSE: 
Via Benzinga
Have $2,000? 2 All-Weather Stocks to Buy This Month
These two companies have what it takes to flourish in the next market crash. 
Via The Motley Fool
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Nasdaq 100 Stocks to Buy Hand Over Fist in July
The high-growth Nasdaq 100 is harboring some serious value with this trio. 
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Vertex to Announce Second-Quarter 2021 Financial Results on July 29
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Eloxx Pharma Sees Data Readout From First Four Arms Of Cystic Fibrosis Study By End Of 2021
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) provided an enrollment update for the ongoing Phase 2 trial of ELX-02 to treat cystic fibrosis (CF) in patients with at... 
Via Benzinga
Can These 2 Beaten-Down Biotechs Rebound? Cathie Wood Thinks So.
Recent trial disappointments scared off some investors. 
Via The Motley Fool
What Are the Odds That Vertex Strikes a Big Acquisition Deal?
It's a near certainty Vertex will make an acquisition -- unless it's acquired first. 
Via The Motley Fool
10 Worst Performing S&P 500 Stocks Of 2021
The S&P 500 has continued its late-2020 momentum in the first two quarters of the year, gaining more than 15% year-to-date. Most U.S. investors have had a lot of winners in... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
Via Benzinga
Could Vertex Pharmaceuticals Be a Prime Acquisition Target?
It's not out of the question. 
Via The Motley Fool
Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation
From Vertex Pharmaceuticals Incorporated
Via Business Wire
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m. ET on Thursday, 16 companies hit new 52-week lows. Areas of Interest: Vertex Pharmaceuticals (NASDAQ:VRTX) was the biggest company by market cap to... 
Via Benzinga
Cramer Gives His Opinion On Bank of America, Advanced Micro Devices And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Martin Marietta Materials, Inc. (NYSE: MLM) is a well-run company. He likes the stock because it doesn't... 
Via Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
Cathie Wood Bought This Stock for a Bargain. Should You Follow?
The company is one of Wood's biggest biotech holdings. 
Via The Motley Fool
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19 Product Safety
Cramer Shares His Thoughts On Vertex Pharma, Snap And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said it's a good opportunity to pick up some Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). The stock... 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.